Alvine Pharmaceuticals Presents Data on the Effects of ALV003 in a Gastric Model That Predicts In Vivo Activity at DDW …
SAN CARLOS, Calif.—-Alvine Pharmaceuticals, Inc., today announced the reporting of scientific data on the performance of its lead compound, ALV003, in a gastric simulation model. The data were presented at the 2010 Digestive Disease Week meeting held in New Orleans, Louisiana.

Read more on Business Wire via Yahoo! Finance